Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve 1.To authorise Mr. Sarang Bharatbhai Pathak (DIN: 02663344) to sign the Financial Statements for the financial year ended 31st March 2026 on behalf of the Board 2.To take note of the consent received from M/s. Dharti Shah & Co. and appoint it as an Internal Auditor of the Company for the Financial Year 2026-2027. 3.To consider and approve the appointment of Mr. Hemant Amrish Parikh as a Non-Executive Non-Independent Director of the Company. 4. To consider and approve the transfer of certain unverified shares to the Unclaimed Suspense Account pending verification of the identity and entitlement of the rightful shareholders and to authorize the Registrar and Share Transfer Agent to process and release such shares from the Unclaimed Suspense Account upon receipt and verification of the prescribed KYC and other supporting documents, subject to confirmation by the Company and applicable laws.
Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Pursuant To Regulations 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Story so far
- Board Meeting Intimation for Board Meeting Intimation For Intimation Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations, 2011
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Apr 30 2026
- Announcement under Regulation 30 (LODR)-Change in Management
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Vivanza Biosciences Ltd. Press Release Apr 28 2026
- Board Meeting Intimation for Board Meeting Intimation For Intimation Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Later from Vivanza Biosciences
- Board Meeting Outcome for Outcome Of Board Meeting To Be Held At 18Th June, 2026
- Vivanza Biosciences Ltd. Press Release Jun 18 2026
- Closure of Trading Window
- Vivanza Biosciences Ltd. Press Release Jun 26 2026
- Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences